Hemofiltration treatment can lower thyroid hormone levels (T3 and T4) over time. However, patients generally remain euthyroid, showing no signs of hypothyroidism during long-term therapy.
Area of Science:
Nephrology
Endocrinology
Internal Medicine
Background:
Hemofiltration is a renal replacement therapy.
Thyroid function can be affected by chronic illness and treatments.
Purpose of the Study:
To assess thyroid function in patients undergoing long-term hemofiltration.
To investigate the impact of hemofiltration on thyroid hormone levels and thyroid status.
Main Methods:
Screening of thyroid function in ten patients on hemofiltration.
Comparison of serum T3, T4, TSH, and TBG levels before and during hemofiltration.
Evaluation of TSH response to TRH stimulation.
Main Results:
A continuous decrease in serum T3 and T4 levels was observed during long-term hemofiltration.
Serum TSH levels also declined, with some individual variations.
Thyroid hormone levels increased during a single treatment, but the T4/TBG ratio remained normal, indicating peripheral euthyroidism.
TSH levels decreased significantly after 5 hours of hemofiltration, possibly due to losses.
Normal TSH response to TRH stimulation was noted.
Conclusions:
Chronic hemofiltration leads to a proportional decline in thyroid hormones and their binding proteins.
Patients on long-term hemofiltration maintain a euthyroid state, evidenced by normal T4/TBG ratios and absence of clinical hypothyroidism.
Hemofiltration may cause TSH losses, but the hypothalamic-pituitary-thyroid axis remains responsive.